Nordson stock trades near record high as Q3 2026 beat and raised guidance draw analyst upgrades

Nordson Corp (ISIN US6556631025) stock is trading close to record levels in late August 2026 after the company delivered a record third quarter for fiscal 2026 and lifted its full-year guidance, while several institutional investors reported new positions in the shares as of August 24, 2026.

On August 24, 2026, recent market data showed Nordson shares opening at $332.24 on the Nasdaq, placing the stock within a few dollars of a reported 52-week high near $338.55 and reflecting a premium valuation versus broader industrial peers.

This elevated price level comes in the wake of Nordson’s latest earnings release for the third quarter of fiscal 2026, where the company reported record quarterly sales, margins and adjusted earnings per share that exceeded prior-year results and consensus estimates, reinforcing investor confidence in its long-term growth trajectory.

Record Q3 2026 sales and earnings

Nordson’s most recent quarterly report covers the third quarter of fiscal 2026, and multiple earnings summaries highlight that the company delivered record sales and profits in that period.

For Q3 fiscal 2026, Nordson generated sales of $818 million, up 10 percent year over year compared with $742 million in the same quarter of the prior fiscal year, driven by 12 percent organic growth with currency effects reported as essentially neutral.

This 10 percent revenue increase demonstrates that Nordson is growing at a solid double-digit pace relative to its own recent history, with organic demand in key end markets such as electronics, medical and industrial adhesives supporting the sales expansion across all major segments.

Profitability also moved higher in the quarter: EBITDA reached $262 million, a 10 percent increase over the prior-year period and equal to 32 percent of sales, marking an all-time high for the company on this metric.

Adjusted operating profit was reported at $226 million, equating to 28 percent of sales, which underscores that Nordson’s cost discipline and pricing actions are translating into robust operating leverage as revenue climbs.

On the bottom line, adjusted earnings per share rose to a record $3.25 in Q3 fiscal 2026, representing a 19 percent increase versus the prior-year adjusted EPS of $2.73 and coming in $0.10 above the high end of management’s guidance range.

This EPS performance also topped the consensus estimate of $3.09 per share that was cited in several analyst recaps, demonstrating that Nordson did not merely meet expectations but delivered a clear beat on profitability.

Reported GAAP net income for the third quarter was $153 million, or $2.73 per share, indicating that even after adjusting for noncash and nonrecurring items, the underlying earnings power of the business remains strong.

The quality of Nordson’s earnings is further supported by its cash generation: free cash flow in the quarter was $237 million, which equates to 144 percent of net income, highlighting a high conversion of accounting profits into cash and giving the company flexibility to fund investment, reduce debt and support shareholder returns.

From a balance-sheet perspective, Nordson ended the quarter with $113 million in cash on hand and net debt of around $1.6 billion, with its leverage ratio cited at 1.7x EBITDA, suggesting a moderate debt load that is being reduced gradually as strong cash flow is applied to deleveraging.

Guidance raised for fiscal 2026

Following the strong Q3 fiscal 2026 performance, Nordson raised its guidance for the full fiscal year 2026, signaling confidence that demand trends and margin performance will remain favorable in the coming quarters.

Earnings summaries describe that the company now expects full-year fiscal 2026 sales to fall within a range of $3,035 million to $3,075 million, compared with a previous outlook of $2,930 million to $3,010 million.

This new sales guidance range implies that Nordson is targeting revenue growth that is ahead of earlier expectations and above an analyst consensus of $2,983 million that was cited as a reference point in coverage of the guidance update.

On the earnings side, Nordson lifted its full-year adjusted EPS guidance to a range of $11.80 to $12.00 for fiscal 2026, up from the prior range of $11.30 to $11.80, reflecting management’s view that margin expansion and operating efficiency can sustain elevated profits.

The updated EPS range also surpasses a published analyst estimate of $11.59 for fiscal 2026, suggesting that, if achieved, Nordson will deliver a full-year earnings beat relative to the expectations embedded in many valuation models.

These guidance revisions tie directly back to operational trends that management emphasized in the latest earnings call, including strong order intake, an expanding backlog and continued growth in high-margin segments such as Advanced Technology Solutions and Medical & Fluid Solutions.

Nordson’s backlog was reported as 35 percent higher than in the prior-year quarter, with this backlog growth described as broad-based rather than concentrated in a single business, indicating diverse sources of demand across industries and geographies.

With a larger backlog and upgraded guidance, Nordson enters the final quarter of fiscal 2026 with a clearer line of sight on revenue and earnings, which can reduce forecasting uncertainty for investors evaluating the stock’s valuation.

Segment performance highlights

Nordson’s record third quarter for fiscal 2026 was not driven solely by one part of the business; segment data show that all three major operating units contributed to growth, with particularly strong performance in Advanced Technology Solutions.

The Advanced Technology Solutions segment posted record quarterly sales of $220 million in Q3 fiscal 2026, up 28 percent year over year and 31 percent on an organic basis when adjusted for currency and portfolio changes.

Segment EBITDA for Advanced Technology Solutions surged 58 percent in the quarter to $66 million, with EBITDA margins expanding to 30 percent from 24 percent one year earlier, making this segment a key driver of overall margin improvement.

Medical & Fluid Solutions also reported record sales, with segment revenue of $231 million in Q3 fiscal 2026, reflecting a 5 percent increase versus the prior-year quarter.

Within Medical & Fluid Solutions, organic growth was cited at nearly 11 percent after adjusting for a divested medical contract manufacturing business that reduced reported sales by around 6 percent, illustrating that core activity in medical tubing and fluid management products remains robust.

EBITDA in the Medical & Fluid Solutions segment increased to $88 million, a 6 percent year-over-year rise, and segment margins reached 38 percent, improving sequentially and supporting the view that this business continues to deliver high returns on capital.

Industrial Precision Solutions, Nordson’s largest segment by revenue, contributed sales of $367 million in Q3 fiscal 2026, up 5 percent year over year and 3 percent organically, as demand for dispensing systems used in packaging, assembly and coating applications held steady.

Management commentary around Industrial Precision Solutions highlighted steady growth rather than rapid acceleration, but the segment’s scale means that even mid-single-digit growth adds materially to total sales and earnings.

Collectively, the segment data show that Nordson’s growth in fiscal 2026 is balanced, with Advanced Technology Solutions delivering outsized percentage gains, Medical & Fluid Solutions maintaining high margins and Industrial Precision Solutions providing core volume and cash flow.

Analyst and investor reaction

The strength of Nordson’s Q3 fiscal 2026 results and raised guidance has been reflected in fresh analyst commentary and institutional investor activity as of August 24, 2026.

Analyst summaries indicate that the average recommendation on Nordson shares is a Moderate Buy, with eight investment analysts split between Buy and Hold ratings, and a consensus price target around $326.57.

This consensus target sits slightly below the recent trading price of $332.24, suggesting that some analysts may need to update their models to reflect the latest guidance and the continued climb in the share price.

Coverage also notes that Nordson trades at a relatively high price-to-earnings ratio, with one source citing a P/E multiple of 33.59 based on current earnings and share price levels, highlighting that investors are willing to pay a premium for the company’s growth and margin profile.

In addition to the existing consensus, fresh analyst actions have emerged: investing news reports describe that one research house has raised its price target on Nordson shares to $375 from $345 while maintaining a Buy rating, placing the new target at the upper end of the current consensus range.

This updated price objective reflects the analyst’s view that Nordson’s improved outlook for fiscal 2026 and 2027 warrants a higher valuation, even as some valuation tools suggest that the shares may be fully valued at levels close to the 52-week high of $338.55.

On the institutional side, multiple recent filings describe new or increased positions in Nordson during the second quarter of calendar 2026, which adds context to the stock’s trading near record highs.

One filing summary states that Korea Investment CORP acquired a new position in Nordson, valued at $14.30 million, in the second quarter, reflecting confidence in the company’s long-term prospects.

Another institutional investor report indicates that PEAK6 LLC initiated a new investment in Nordson stock valued at $6.92 million, suggesting that the Q3 earnings momentum and raised guidance are attracting interest from diversified investment firms.

A separate filing recap notes that Gallo Partners LP purchased 8,393 Nordson shares in the second quarter, with the position valued at $2.53 million, while other wealth management firms such as Elevation Point Wealth Partners LLC disclosed Nordson stakes of around $1.15 million.

Collectively, these institutional moves underscore that professional investors are adding exposure to Nordson around the time of its record quarter and guidance upgrade, even though the valuation multiple is elevated compared with many industrial peers.

Valuation, backlog and strategic positioning

With Nordson stock trading at $332.24 and a cited price-to-earnings ratio of 33.59, valuation is an important consideration for retail investors evaluating the shares in late August 2026.

The combination of double-digit revenue growth, expanding margins, strong free cash flow and a growing backlog provides a fundamental explanation for why the market is assigning a premium multiple to Nordson compared with more cyclical industrial names.

Nordson’s reported 35 percent year-over-year increase in backlog at the end of Q3 fiscal 2026 is particularly notable, because it provides visibility into future sales and suggests that current orders are not merely a short-term spike but part of a sustained demand trend.

Importantly, earnings recaps emphasize that this backlog growth is spread across all three operating segments, rather than being concentrated only in Advanced Technology Solutions or in a single geography, which mitigates concentration risk.

Nordson’s strategic focus on precision dispensing equipment and systems, which are embedded within customers’ production processes and often mission-critical, also supports recurring demand and pricing power.

By supplying equipment that applies adhesives, coatings, sealants and polymers in industrial and medical applications, Nordson participates in a wide range of end markets including electronics assembly, packaging, automotive, medical devices and general industrial manufacturing.

In many of these applications, customers value reliability, uptime and precise material application more than lowest possible upfront cost, which allows Nordson to compete on performance and service rather than purely on price.

This positioning, combined with ongoing innovation in dispensing technologies and controls, helps explain why Nordson can sustain EBITDA margins in the low 30 percent range across the enterprise and even higher in segments such as Medical & Fluid Solutions.

From a capital allocation standpoint, Nordson’s strong free cash flow and moderate leverage ratio of 1.7x give it flexibility to continue investing in research and development, pursuing bolt-on acquisitions and returning capital to shareholders via dividends or share repurchases.

The balance between organic growth and targeted acquisitions has historically been a key part of Nordson’s strategy, and the current backlog and guidance suggest that organic demand remains strong even before any incremental contribution from future deals.

For investors, the key questions around valuation include whether Nordson can maintain double-digit organic growth in Advanced Technology Solutions, keep margins elevated in Medical & Fluid Solutions and gradually accelerate growth in Industrial Precision Solutions without significant macroeconomic headwinds.

Product snapshot - precision dispensing systems

A representative example of Nordson’s business model is its precision dispensing systems used in electronics and industrial assembly, which are designed to apply adhesives, coatings and other materials with high accuracy and repeatability.

These systems often integrate hardware such as pumps, valves and nozzles with sophisticated controls and software that manage flow rates, shot sizes and patterns, enabling customers to automate production steps that were previously manual or less controlled.

In electronics manufacturing, for instance, Nordson’s dispensing equipment can be used to apply underfill materials around semiconductor packages, conformal coatings on printed circuit boards and thermal interface materials for heat management, processes that require tight tolerances to ensure product reliability.

Similarly, in industrial applications such as automotive or packaging, Nordson systems help apply structural adhesives and sealants in body assembly or packaging lines, improving bond strength, reducing waste and enhancing line speed.

The high value-add nature of these products supports the margins seen in Nordson’s segment results and provides a foundation for recurring revenue from consumables, spare parts, upgrades and service contracts.

Nordson stock price context

As of the most recent trading data referenced on August 24, 2026, Nordson stock opened at $332.24 on the Nasdaq, with the shares cited as trading close to a 52-week high of $338.55.

That price level implies that Nordson is valued above the current analyst consensus price target of $326.57, highlighting that the market is already factoring in a significant portion of the improved fiscal 2026 guidance and record Q3 results.

For retail investors, the key takeaway is that Nordson stock currently reflects strong operational momentum, including 10 percent year-over-year sales growth in Q3 fiscal 2026, a 19 percent increase in adjusted EPS to $3.25 and upgraded full-year EPS guidance to a range of $11.80 to $12.00, supported by a 35 percent higher backlog and robust free cash flow conversion.

Fact box

Company: Nordson Corp

ISIN: US6556631025

Ticker: NDSN

Exchange: Nasdaq

Price (as of August 24, 2026, market open): $332.24 USD

Market cap: data consistent with a P/E multiple of 33.59 and adjusted EPS guidance in the $11.80 to $12.00 range for fiscal 2026

Sector / Industry: Industrials - precision dispensing equipment and systems

Index membership: broader US equity benchmarks and industrial indices, with inclusion consistent with the company’s size and sector

Next earnings date: not specified in the available futures calendar for dates beyond August 24, 2026